{"id":"NCT01456169","sponsor":"Takeda","briefTitle":"A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone","officialTitle":"A Phase-3 Randomized, Double-Blind, Efficacy and Safety Study Evaluating the Fixed Dose Combinations of TAK-491 Plus Chlorthalidone (40/12.5 mg and 40/25 mg) in Subjects With Grades 2 or 3 Essential Hypertension, Who Do Not Achieve Target Blood Pressure Following Treatment With TAK-491 40 mg Monotherapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-10","primaryCompletion":"2012-12","completion":"2013-01","firstPosted":"2011-10-20","resultsPosted":"2014-04-23","lastUpdate":"2014-04-23"},"enrollment":507,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Essential Hypertension"],"interventions":[{"type":"DRUG","name":"Azilsartan medoxomil/placebo","otherNames":["TAK-491","EDARBI"]},{"type":"DRUG","name":"Azilsartan medoxomil - chlorthalidone","otherNames":["TAK-491CLD","Edarbyclor"]}],"arms":[{"label":"Azilsartan medoxomil 40 mg","type":"ACTIVE_COMPARATOR"},{"label":"Azilsartan medoxomil + chlorthalidone 40/12.5 mg","type":"EXPERIMENTAL"},{"label":"Azilsartan medoxomil + chlorthalidone 40/25 mg","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of the fixed dose combinations of azilsartan medoxomil plus chlorthalidone (40/12.5 and 40/25 mg), once daily, in participants with grades 2 or 3 essential hypertension who do not reach target blood pressure following treatment with 40 mg azilsartan medoxomil monotherapy after 4 weeks.","primaryOutcome":{"measure":"Change From Baseline to Week 8 in Trough, Sitting, Clinic Systolic Blood Pressure","timeFrame":"Baseline (of the double-blind treatment period) and Week 8","effectByArm":[{"arm":"Azilsartan Medoxomil 40 mg","deltaMin":150.7,"sd":0.96},{"arm":"Azilsartan Medoxomil + Chlorthalidone 40/12.5 mg","deltaMin":149.8,"sd":0.98},{"arm":"Azilsartan Medoxomil + Chlorthalidone 40/25 mg","deltaMin":149.8,"sd":0.95}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":108,"countries":["Bulgaria","Estonia","France","Germany","Hungary","Italy","Lithuania","Netherlands","Poland","Serbia","Slovakia","Spain","Sweden","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":507},"commonTop":["Blood creatinine increased","Headache","Nasopharyngitis","Dizziness","Hypotension"]}}